Page 159 - Read Online

Page 14 of 15 Dokko et al. Vessel Plus 2022;6:53 https://dx.doi.org/10.20517/2574-1209.2022.11

valves: update 2020. J Am Heart Assoc 2020;9:e018506. DOI PubMed PMC
8. Herold J, Herold-Vlanti V, Sherif M, et al. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in
patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR). BMC
Cardiovasc Disord 2017;17:298. DOI PubMed PMC
9. Mentias A, Saad M, Girotra S, et al. Impact of pre-existing and new-onset atrial fibrillation on outcomes after transcatheter aortic valve
replacement. JACC Cardiovasc Interv 2019;12:2119-29. DOI PubMed PMC
10. Kalra R, Patel N, Doshi R, Arora G, Arora P. Evaluation of the incidence of new-onset atrial fibrillation after aortic valve replacement.
JAMA Intern Med 2019;179:1122-30. DOI PubMed PMC
11. Indja B, Woldendorp K, Vallely MP, Grieve SM. New onset atrial fibrillation following transcatheter and surgical aortic valve
replacement: a systematic review and Meta-analysis. Heart Lung Circ 2020;29:1542-53. DOI PubMed
12. Motloch LJ, Reda S, Rottlaender D, et al. Postprocedural atrial fibrillation after transcatheter aortic valve implantation versus surgical
aortic valve replacement. Ann Thorac Surg 2012;93:124-31. DOI PubMed
13. Tanawuttiwat T, O'Neill BP, Cohen MG, et al. New-onset atrial fibrillation after aortic valve replacement: comparison of transfemoral,
transapical, transaortic, and surgical approaches. J Am Coll Cardiol 2014;63:1510-9. DOI PubMed
14. Vora AN, Dai D, Matsuoka R, et al. Incidence, management, and associated clinical outcomes of new-onset atrial fibrillation following
transcatheter aortic valve replacement: an analysis from the STS/ACC TVT registry. JACC Cardiovasc Interv 2018;11:1746-56. DOI
PubMed
15. Saxena S. A review of the incidence and management of new-onset atrial fibrillation post transcatheter aortic valve implantation.
AJBSR 2020;8:117-21. DOI
16. Tarantini G, Mojoli M, Windecker S, et al. Prevalence and impact of atrial fibrillation in patients with severe aortic stenosis
undergoing transcatheter aortic valve replacement: an analysis from the SOURCE XT prospective multicenter registry. JACC
Cardiovasc Interv 2016;9:937-46. DOI PubMed
17. Ding Y, Wan M, Zhang H, Wang C, Dai Z. Comparison of postprocedural new-onset atrial fibrillation between transcatheter and
surgical aortic valve replacement: a systematic review and meta-analysis based on 16 randomized controlled trials. Medicine
(Baltimore) 2021;100:e26613. DOI PubMed PMC
18. Shahim B, Malaisrie SC, George I, et al. Postoperative atrial fibrillation or flutter following transcatheter or surgical aortic valve
replacement: PARTNER 3 trial. JACC Cardiovasc Interv 2021;14:1565-74. DOI PubMed
19. Ejiofor JI, Yammine M, Harloff MT, et al. Reoperative surgical aortic valve replacement versus transcatheter valve-in-valve
replacement for degenerated bioprosthetic aortic valves. Ann Thorac Surg 2016;102:1452-8. DOI PubMed
20. New York State Department of Health. Vital Statistics of New York State 2018. Published 2018. Accessed January 24, 2022.
21. New York State Department of Health. Statewide Planning and Research Cooperative System (SPARCS). Accessed 2021.
22. Axtell AL, Moonsamy P, Melnitchouk S, et al. Preoperative predictors of new-onset prolonged atrial fibrillation after surgical aortic
valve replacement. J Thorac Cardiovasc Surg 2020;159:1407-14. DOI PubMed
23. Amar D, Zhang H, Leung DH, Roistacher N, Kadish AH. Older age is the strongest predictor of postoperative atrial fibrillation.
Anesthesiology 2002;96:352-6. DOI PubMed
24. Auer J, Weber T, Berent R, Ng CK, Lamm G, Eber B. Risk factors of postoperative atrial fibrillation after cardiac surgery. J Card Surg
2005;20:425-31. DOI PubMed
25. Mariscalco G, Biancari F, Zanobini M, et al. Bedside tool for predicting the risk of postoperative atrial fibrillation after cardiac
surgery: the POAF score. J Am Heart Assoc 2014;3:e000752. DOI PubMed PMC
26. Mortazavi SH, Oraii A, Goodarzynejad H, et al. Utility of the CHA DS -VASc score in prediction of postoperative atrial fibrillation
2
2
after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2022;36:1304-9. DOI PubMed
27. Mahmaljy H, Tawney A, Young M. Transcatheter Aortic Valve Replacement. 2022 May 5. In: StatPearls [Internet]. Treasure Island
(FL): StatPearls Publishing; 2022. PubMed
28. Murdoch DJ, Webb JG. Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses. J Thorac Dis
2018;10:S3573-7. DOI PubMed PMC
29. Malik AH, Yandrapalli S, Zaid S, et al. Valve-in-valve transcatheter implantation versus redo surgical aortic valve replacement. Am J
Cardiol 2020;125:1378-84. DOI PubMed
30. Jeong HK, Yoon N, Kim JH, et al. Post-operative atrial fibrillation impacts on outcomes in transcatheter and surgical aortic valve
replacement. Front Cardiovasc Med 2021;8:789548. DOI PubMed PMC
31. Biviano AB, Nazif T, Dizon J, et al. Atrial fibrillation is associated with increased mortality in patients undergoing transcatheter aortic
valve replacement: insights from the Placement of Aortic Transcatheter Valve (PARTNER) trial. Circ Cardiovasc Interv
2016;9:e002766. DOI PubMed PMC
32. Stamou SC, Chen K, James TM, et al. Predictors and outcomes of patient-prosthesis mismatch after transcatheter aortic valve
replacement. J Card Surg 2020;35:360-6. DOI PubMed
33. Taylor NE, O’Brien S, Edwards FH, Peterson ED, Bridges CR. Relationship between race and mortality and morbidity after valve
replacement surgery. Circulation 2005;111:1305-12. DOI PubMed
34. Nathan AS, Yang L, Yang N, et al. Racial, ethnic, and socioeconomic disparities in access to transcatheter aortic valve replacement
within major metropolitan areas. JAMA Cardiol 2022;7:150-7. DOI PubMed PMC
35. Bilfinger T, Nemesure A, Pyo R, et al. Distressed communities index in patients undergoing transcatheter aortic valve implantation in